199 related articles for article (PubMed ID: 35856247)
1. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism.
Kaur G; Bhadada SK; Santra M; Pal R; Sarma P; Sachdeva N; Dhiman V; Dahiya D; Saikia UN; Chakraborty A; Sood A; Prakash M; Behera A; Rao SD
J Bone Miner Res; 2022 Oct; 37(10):1860-1875. PubMed ID: 35856247
[TBL] [Abstract][Full Text] [Related]
2. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
Park HS; Lee YH; Hong N; Won D; Rhee Y
Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
[TBL] [Abstract][Full Text] [Related]
4. Loss of p27 expression is associated with MEN1 gene mutations in sporadic parathyroid adenomas.
Borsari S; Pardi E; Pellegata NS; Lee M; Saponaro F; Torregrossa L; Basolo F; Paltrinieri E; Zatelli MC; Materazzi G; Miccoli P; Marcocci C; Cetani F
Endocrine; 2017 Feb; 55(2):386-397. PubMed ID: 27038812
[TBL] [Abstract][Full Text] [Related]
5. Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
[TBL] [Abstract][Full Text] [Related]
6. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
[TBL] [Abstract][Full Text] [Related]
7. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
8. Genetics of parathyroid tumours.
Thakker RV
J Intern Med; 2016 Dec; 280(6):574-583. PubMed ID: 27306766
[TBL] [Abstract][Full Text] [Related]
9. Genotype-Phenotype Correlations in Asian Indian Children and Adolescents with Primary Hyperparathyroidism.
Sharma A; Memon S; Lila AR; Sarathi V; Arya S; Jadhav SS; Hira P; Garale M; Gosavi V; Karlekar M; Patil V; Bandgar T
Calcif Tissue Int; 2022 Sep; 111(3):229-241. PubMed ID: 35567607
[TBL] [Abstract][Full Text] [Related]
10. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract][Full Text] [Related]
11. [Predicting the presence of
Mokrysheva NG; Eremkina AK; Miliutina AP; Salimkhanov RK; Aboishava LA; Bibik EE; Gorbacheva AM; Elfimova AR; Kovaleva EV; Popov SV; Melnichenko GA
Probl Endokrinol (Mosk); 2023 Nov; 69(5):4-15. PubMed ID: 37968947
[TBL] [Abstract][Full Text] [Related]
12. [Severe bone complications of primary hyperparathyroidism in a young patient with the rare verified mutation of
Eremkina AK; Sazonova DV; Bibik EE; Sheikhova AZ; Khairieva AV; Buklemishev YV; Mokrysheva NG
Probl Endokrinol (Mosk); 2022 Feb; 68(1):81-93. PubMed ID: 35262299
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism.
Minisola S; Arnold A; Belaya Z; Brandi ML; Clarke BL; Hannan FM; Hofbauer LC; Insogna KL; Lacroix A; Liberman U; Palermo A; Pepe J; Rizzoli R; Wermers R; Thakker RV
J Bone Miner Res; 2022 Nov; 37(11):2315-2329. PubMed ID: 36245271
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
15. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
[TBL] [Abstract][Full Text] [Related]
16. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
17. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism.
Alvelos MI; Vinagre J; Fonseca E; Barbosa E; Teixeira-Gomes J; Sobrinho-Simões M; Soares P
Eur J Endocrinol; 2013 Feb; 168(2):119-28. PubMed ID: 23093699
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathogenesis of primary hyperparathyroidism.
Cetani F; Pardi E; Borsari S; Marcocci C
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]